Sensei Biotherapeutics, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Sensei Biotherapeutics, Inc. (SNSE) is 879.30M

According to Sensei Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 879.30M. This represents a change of 25.05% compared to the average of 3.50M of the last 4 quarters.

Sensei Biotherapeutics, Inc. (SNSE) Historical Enterprise Value (quarterly & annually)

How has SNSE Enterprise Value performed in the past?

The mean historical Enterprise Value of Sensei Biotherapeutics, Inc. over the last ten years is 238.44M. The current 879.30M Enterprise Value has changed 36.78% with respect to the historical average. Over the past ten years (40 quarters), SNSE's Enterprise Value was at its highest in in the March 2020 quarter at 578.12M. The Enterprise Value was at its lowest in in the March 2026 quarter at -110465960.96.

Sensei Biotherapeutics, Inc. (SNSE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sensei Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sensei Biotherapeutics, Inc. (SNSE) Average Enterprise Value

How has SNSE Enterprise Value performed in the past?

The current Enterprise Value of Sensei Biotherapeutics, Inc. (SNSE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sensei Biotherapeutics, Inc. (SNSE) Enterprise Value vs. Peers

How is SNSE’s Enterprise Value compared to its peers?

Sensei Biotherapeutics, Inc.’s Enterprise Value is greater than Imunon, Inc. (6.78M), greater than Bolt Biotherapeutics, Inc. (15.19M), greater than Evogene Ltd. (-2816602.61), greater than Cocrystal Pharma, Inc. (14.89M), greater than Dogwood Therapeutics, Inc. (48.36M), greater than Marker Therapeutics, Inc. (8.34M), greater than Cellectar Biosciences, Inc. (-13286410.00), greater than AEON Biopharma, Inc. (10.22M), greater than Cingulate Inc. (47.25M), greater than Traws Pharma, Inc. (5.02M),

Build a custom stock screener for Sensei Biotherapeutics, Inc. (SNSE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sensei Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sensei Biotherapeutics, Inc. (SNSE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sensei Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.